AJR Join ARRS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by KATTAN, K. R.
Right arrow Search for Related Content
PubMed
Right arrow Articles by KATTAN, K. R.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

THICKENING OF THE HEEL-PAD ASSOCIATED WITH LONG-TERM DILANTIN THERAPY

KENNETH R. KATTAN M.D.

Thickening of the heel-pad is added to the list of side effects of Dilantin medication.

Any measurement above 20 mm. in a white patient was considered abnormal. Only 1 of 43 controls measured above this value, while in patients receiving Dilantin the percentage of patients manifesting abnormally thickened heel-pads increased steadily with length of treatment; after 10 years 7 out of 12 patients showed this change.

Dilantin medication should be included in the differential diagnosis of heel-pad thickening.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1975 by the American Roentgen Ray Society.